Table 1.
Common name | IUPAC name |
---|---|
Abscisic acid (ABA) | (2Z,4E)-5-((S)-1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-enyl)-3-methylpenta-2,4-dienoic acid |
Pyrabactin | 4-bromo-N-(pyridin-2-ylmethyl)naphthalene-1-sulfonamide |
Apyrabactin | N-benzyl-4-bromonaphthalene-1-sulfonamide |
Quinabactin | N-(2-oxo-1-propyl-1,2,3,4-tetrahydroquinolin-6-yl)-1-p-tolylmethanesulfonamide |
Compound #32 | 2-oxo-N-(pyridin-2-ylmethyl)-1,2-dihydrobenzo[cd]indole-6-sulfonamide |
Compound #68 | ethyl 2-(1-ethyl-2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamido)acetate |
Compound #71 | (S)-1-ethyl-2-oxo-N-(2-(tetrahydrofuran-2-yl)ethyl)-1,2-dihydrobenzo[cd]indole-6-sulfonamide |
Compound #98 | 2-(4-bromonaphthalene-1-sulfonamido)-5-(methylthio)pentanoic acid |
PBI-51 | (4S,5R)-4-hydroxy-4-((Z)-5-hydroxy-3-methylpent-3-en-1-ynyl)-3,3,5-trimethylcyclohexanone |
DFPM | (5-(3,4-dichlorophenyl)furan-2-yl)(piperidin-1-yl)methanethione |
3′-hexylsulfanyl-ABA (AS6) | (2Z,4E)-5-((S)-3-(hexylthio)-1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-enyl)-3-methylpenta-2,4-dienoic acid |
Salicylic acid (SA) | 2-hydroxybenzoic acid |
INA | 2,6-dichloroisonicotinic acid |
Benzothiadiazole (BTH) | S-methyl 1,2,3-benzothiadiazole-7-carbothioate |
Imprimatin C1 | (E)-N′-(4-chlorobenzoyloxy)-2-(2-oxopyrrolidin-1-yl)acetimidamide |
Imprimatin C2 | (E)-N′-(3,4-dichlorobenzoyloxy)-2-(2-oxopyrrolidin-1-yl)acetimidamide |
4-CBA | 4-chlorobenzoic acid |
3,4-DCBA | 3,4-dichlorobenzoic acid |
3,5-DCBA | 3,5-dichlorobenzoic acid |
IAA | indol-3-acetic acid |
NAA | 1-naphthaleneacetic acid |
2,4-D | 2,4-dichlorophenoxyacetic acid |
Picloram | 4-amino-3,5,6-trichloro-2-pyridinecarboxylic acid |
5-F-IAA | 5-fluoro-indol-3-acetic acid |
BH-IAA | 8-(tert-butoxycarbonylamino)-2-(1H-indol-3-yl)octanoic acid |
PEO-IAA | 2-(1H-indol-3-yl)-4-oxo-4-phenylbutanoic acid |
Auxinole | 4-(2,4-dimethylphenyl)-2-(1H-indol-3-yl)-4-oxobutanoic acid |
FITC-IAA | 2-(1-(3′,6′-dihydroxy-3-oxo-3H-spiro[isobenzofuran-1,9′-xanthene]-5-ylcarbamothioyl)-1H-indol-3-yl)acetic acid |
RITC-IAA | N-(9-(2-carboxy-6-(3-(carboxymethyl)-1H-indole-1-carbothioamido)phenyl)-6-(diethylamino)-3H-xanthen-3-ylidene)-N-ethylethanaminium |
Terfestatin A (TrfA) | (2S,3R,4S,5S,6R)-2-(2,4-dihydroxy-3,6-diphenylphenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol |
trans-Zeatin (tZ) | (E)-4-(9H-purin-6-ylamino)-2-methylbut-2-en-1-ol |
N6-(2-hydroxy-3-methylbenzylamino) purine (PI-55) | 2-((9H-purin-6-ylamino)methyl)-6-methylphenol |
N6-(2,5-dihydroxybenzylamino) purine (LGR-991) | 2-((9H-purin-6-ylamino)methyl)benzene-1,4-diol |
N6-(benzyloxymethyl) adenosine (BOMA) | (2R,3R,4S,5R)-2-(6-(benzyloxymethylamino)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol |
S-4893 | 3-(6-chloro-4-phenylquinazolin-2-ylamino)propan-1-ol |
N6-benzyladenine (BA)/6-benzylaminopurine (BAP) | N-benzyl-7H-purin-6-amine |
Brassinolide (BL) | (3aS,5S,6R,7aR,9aS,10R)-10-((2S,3S,4S,5R)-3,4-dihydroxy-5,6-dimethylheptan-2-yl)-5,6-dihydroxy-7a,9a-dimethyltetradecahydro-1H-benzo[c]indeno[5,4-e]oxepin-3(12bH)-one |
Bikinin (BIK) | 4-(5-bromopyridin-2-ylamino)-4-oxobutanoic acid |
Brassinopride (BRP) | N-benzyl-N-(1-cyclopropylethyl)-4-fluorobenzamide |
Castasterone (CS) | (2R,3S,5S,10R,13S)-17-((2S,3S,4S,5S)-3,4-dihydroxy-5,6-dimethylheptan-2-yl)-2,3-dihydroxy-10,13-dimethyltetradecahydro-1H-cyclopenta[a]phenanthren-6(10H)-one |
Alexa Fluor 647-castasterone (AFCS) | 2-((1E,3E,5Z)-5-(3-(6-(5-(2-((E)-((2R,3S,10R,13S)-17-((2S,3S,4S,5S)-3,4-dihydroxy-5,6-dimethylheptan-2-yl)-2,3-dihydroxy-10,13-dimethyloctahydro-1H-cyclopenta[a]phenanthren-6(10H,12H,13H,14H,15H,16H,17H)-ylidene)aminooxy)acetamido)pentylamino)-6-oxohexyl)-3-methyl-5-sulfo-1-(3-sulfopropyl)indolin-2-ylidene)penta-1,3-dienyl)-3,3-dimethyl-5-sulfo-1-(3-sulfopropyl)-3H-indolium |
(+)-Strigol | (3aR,5S,8bS,E)-5-hydroxy-8,8-dimethyl-3-(((R)-4-methyl-5-oxo-2,5-dihydrofuran-2-yloxy)methylene)-3,3a,4,5,6,7,8,8b-octahydro-2H-indeno[1,2-b]furan-2-one |
Karrikin1 (KAR1) | 3-methyl-2H-furo[2,3-c]pyran-2-one |
GR24 | (3aR,8bS,E)-3-(((R)-4-methyl-5-oxo-2,5-dihydrofuran-2-yloxy)methylene)-3,3a,4,8b-tetrahydro-2H-indeno[1,2-b]furan-2-one |
Cyano-isoindole-strigolactone-analog-1 (CISA-1) | (E)-ethyl 2-(1-(but-3-enyl)-3-cyano-2H-isoindol-2-yl)-3-(4-methyl-5-oxo-2,5-dihydrofuran-2-yloxy)acrylate |
4-Br debranone | 5-(4-bromophenoxy)-3-methylfuran-2(5H)-one |
3′-methyl-GR24 | (3aR,8bS,Z)-3-(((R)-3,4-dimethyl-5-oxo-2,5-dihydrofuran-2-yloxy)methylene)-3,3a,4,8b-tetrahydro-2H-indeno[1,2-b]furan-2-one |
tia-3′-methyl-debranones-like molecule | 5-((4-Chlorophenyl)thio)-3,4-dimethylfuran-2(5H)-one |
AR36 | (2E,4E)-Methyl 5-((3,4-Dimethyl-5-Oxo-2,5-Dihydrofuran-2-Yl)Oxy)-4-Methylpenta-2,4-Dienoate |
BOPIDY | 4,4-difluoro-4-bora-3α,4α-diaza-s-indacene |
HR | BF2 Chelate of (Z)-5-(3,5-dimethyl-1Hpyrrol-2-yl)-N-(4-((E)-1,4-dimethyl-2-((4-methyl-5-oxo-2,5-dihydrofuran-2-yloxy)methylene)-3-oxo-1,2,3,4-tetrahydrocyclopenta[b]indol-7-yl)phenyl)-5-(3,5-dimethyl-2H-pyrrol-2-ylidene)pentanamide |
EG | BF2 Chelate of (E)-6-((3,5-dimethyl-1H-pyrrol-2-yl) (3,5-dimethyl-2H-pyrrol-2-ylidene)methyl)-2,2-dimethyl-2H-pyran-4(3H)-one |
Both the common name and the IUPAC name of each compound are listed. When an abbreviation for the compound is available, it is included in the parenthesis following the corresponding common name.